Trulicity (dulaglutide) NDC 50090-6453

Product information

Brand name (proprietary)

Trulicity

Generic name (nonproprietary)

dulaglutide

Active ingredients

Dulaglutide — .75 mg/.5mL

Dosage form

Injection, Solution

Route

Subcutaneous

Labeler

A-S Medication Solutions

Product type

Prescription drug

Marketing category

BLA — Biologics License ApplicationApplication BLA 125469

Marketing start

Sep 18, 2014

Listing expires

Dec 31, 2026

Other FDA classes

Glucagon-Like Peptide 1 (Chemical structure)Glucagon-like Peptide-1 (GLP-1) Agonists (Mechanism)

Identifiers

Product ID 50090-6453_ef6fe0e3-e633-4ae0-a41e-550140116e5aSPL ID ef6fe0e3-e633-4ae0-a41e-550140116e5aSPL set ID a923e467-fea3-431c-b7e4-c9669af607b7RxCUI 1551295, 1551300UNII WTT295HSY5

Pharmacologic class

GLP-1 Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N450090645300 followed by a unit qualifier and the quantity Copy

Package 50090-6453-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under BLA 125469

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.